$87.2 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 116 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BSX | New | BOSTON SCIENTIFIC CORP | $1,184,000 | – | 50,650 | +100.0% | 1.36% | – |
FUL | New | FULLER H B CO | $823,000 | – | 18,700 | +100.0% | 0.94% | – |
CYTX | New | CYTORI THERAPEUTICS INC | $811,000 | – | 387,852 | +100.0% | 0.93% | – |
ANGO | New | ANGIODYNAMICS INC | $644,000 | – | 44,850 | +100.0% | 0.74% | – |
EGHT | New | 8X8 INC NEW | $552,000 | – | 37,800 | +100.0% | 0.63% | – |
CR | New | CRANE CO | $465,000 | – | 8,200 | +100.0% | 0.53% | – |
USPH | New | U S PHYSICAL THERAPY INC | $437,000 | – | 7,250 | +100.0% | 0.50% | – |
BMY | New | BRISTOL MYERS SQUIBB CO | $414,000 | – | 5,625 | +100.0% | 0.48% | – |
ENTL | New | ENTELLUS MED INC | $411,000 | – | 22,500 | +100.0% | 0.47% | – |
EDAP | New | EDAP TMS S Asponsored adr | $391,000 | – | 118,000 | +100.0% | 0.45% | – |
PFIE | New | PROFIRE ENERGY INC | $309,000 | – | 278,537 | +100.0% | 0.35% | – |
CASC | New | CASCADIAN THERAPEUTICS INC | $290,000 | – | 307,400 | +100.0% | 0.33% | – |
TAP | New | MOLSON COORS BREWING COcl b | $288,000 | – | 2,850 | +100.0% | 0.33% | – |
MMSI | New | MERIT MED SYS INC | $208,000 | – | 10,500 | +100.0% | 0.24% | – |
MU | New | MICRON TECHNOLOGY INC | $203,000 | – | 14,750 | +100.0% | 0.23% | – |
APPY | New | VENAXIS INC | $165,000 | – | 47,092 | +100.0% | 0.19% | – |
GIG | New | GIGPEAK INC | $135,000 | – | 69,000 | +100.0% | 0.16% | – |
DXTRQ | New | DEXTERA SURGICAL INC | $93,000 | – | 51,403 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-20
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
LILY ELI & CO | 41 | Q3 2023 | 6.9% |
PFIZER INC | 41 | Q3 2023 | 2.9% |
ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
DONALDSON INC | 41 | Q3 2023 | 1.3% |
VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
US BANCORP DEL | 41 | Q3 2023 | 0.8% |
BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-09 |
13F-HR | 2024-01-22 |
13F-HR | 2023-11-02 |
13F-HR | 2023-07-21 |
SC 13G/A | 2023-05-15 |
13F-HR | 2023-05-09 |
SC 13G/A | 2023-02-09 |
SC 13G | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.